Ectopic expression of lineage master regulators induces transdifferentiation. Whether cell fate transitions can be induced during various developmental stages has never been systemically examined. Here we discovered that amongst different developmental stages, embryonic stem cells (ESCs) were resistant to cell fate conversion induced by the melanocyte lineage master regulator MITF. We generated a transgenic system and found that in ESCs, the pluripotency master regulator, OCT4, counteracts prodifferentiation induced by MITF by physical interference with MITF transcriptional activity. We further found that ESCs must be released from OCT4-maintained pluripotency prior to ectopically induced differentiation. Moreover, OCT4 induction in various differentiated cells repressed their lineage identity in vivo. Alongside, chromatin architecture combined with ChIP-seq analysis suggested that OCT4 competes with various lineage master regulators for binding promoters and enhancers. Our analysis reveals pluripotency and transdifferentiation regulatory principles and could open new opportunities in the field of regenerative medicine.
Introduction
An ultimate goal of regenerative medicine is to produce functional differentiated cells suitable for transplantation. For this purpose, two main reprogramming approaches are currently available. One reprograms somatic cells into induced pluripotent stem cells (iPSCs) by the induction of the four Yamanaka factors 1,2,3 and subsequently differentiates them into the desired somatic cells. The other is transdifferentiation, which is the direct conversion of one somatic cell type to another without going through pluripotency, by the manipulation of one or more ectopic master regulator transcription factors 4, 5 . Both of these reprogramming approaches face critical challenges of producing optimized cultures of reprogrammed target cells with high level of efficiency and quality. In order to meet these challenges a fully controlled directed differentiation and transdifferentiation is needed.
To date numerous studies have manipulated stem cell differentiation and cell fate redirection by cell culture growth media and microenvironment conditions 6 . However, it remains to be known whether pluripotent stem cells (ESCs or iPSCs) would be directly differentiated by inducing expression of a lineage specific master regulator that is known to successfully redirect cell fate in somatic cells ESCs are pluripotent cells derived from the inner cell mass of blastocyst-stage embryos that have the capacity to give rise to differentiated derivatives from all three primary germ layers: ectoderm, mesoderm, and endoderm 7 . iPSCs share chromatin structure and gene expression characteristics with ESCs 8 . ESCs differentiation into specialized cells requires the use of differentiation media that contains specific growth and signaling factors per se or in combination with the expression of defined transcription factors 6 .
This approach has been used to differentiate ESCs into melanocytes 9,10 ,11 .
Microphthalmia-associated transcription factor (MITF) is a basic helix-loop-helix (bHLH-zip) transcription factor that serves as the master regulator of the melanocyte lineage. Nonfunctional MITF results in lack of melanocytes 12, 13 . Alternative promoters give rise to various MITF isoforms differing in their N-termini; promoter use is regulated in a tissue-specific manner 14 . The promoters of genes regulated by the melanocyte specific isoform, M-MITF, contain the consensus E-box sequence 12 . MITF regulates the transcription of melanocyte-specific genes: TRPM1, TYR, TYRP1, DCT, SILV, and MLANA as well as genes involved in cell survival and proliferation such as BCL2, CDK2, and DICER 15 . MITF has a critical role in melanoma as it is required for survival and controls the proliferative, invasive, and metastatic properties of melanoma cells 16, 17 .
It was previously reported that ectopic expression of Mitf converts fibroblasts into cells with melanocyte characteristics, although only a minority of the Mitf-transfected cells had a melanocyte-like cell appearance 18 . A recent study showed that about 10% of the fibroblasts infected with retroviruses carrying a combination of transcription factors MITF, SOX10, and PAX3 acquire melanocyte properties 19 .
In an effort to produce highly efficient, directed differentiation and transdifferentiation systems, we have analyzed effects of inducible expression of the MITF master regulator in differentiation promoting growth conditions in both somatic cells and pluripotent ESCs. We developed a transgenic system in which Mitf expression was Dox-inducible that enabled us to screen MITF reprogramming potential on different primary cell types originating from the same animal model and also to direct differentiation of pluripotent mouse ESCs (mESCs).
Results

Generation of doxycycline-inducible Mitf knock-in reprogrammable system
In order to test the potential of different cell types to switch lineage in response to a single lineage master regulator expression, we established a Dox-inducible mouse model using the melanocyte lineage specific isoform of Mitf (M-Mitf). M-Mitf serves here as an exclusive inducer of differentiation and transdifferentiation unlike the conventional method based on media promoting factors. We used KH2 mESCs that constitutively express the M2 reverse tetracycline transactivator (M2rtTA) 20 into the correctly targeted mESCs ( Fig. 1a, b ). mESCs were injected into host E3.5 mouse blastocysts and chimeric embryos were dissected at 13.5E and were used to generate mouse embryonic fibroblast cultures (MEFs). Chimeric newborn P1-3 mice were also generated and somatic tissues were analyzed (Fig. 1c ). The constitutively expressed mCherry allele and puromycin resistance cassettes allowed us to easily isolate and purify the Mitf transgenic cells from chimeric cultures and animals.
Highly efficient transdifferentiation of MEFs into melanocyte-like cells by MITF
Somatic cell transdifferentiation into melanocyte-like cells has been previously reported in MEFs at efficiencies of 2% to 10% 18, 19 . Although transdifferentiation is considered to be superior in terms of reprogramming efficiency as compared to conventional iPSCs reprogramming, the acceptable range of transdifferentiation protocols is up to 20% efficiency of the source cell population 21, 22, 23 .
We first aimed to validate the ability of Dox-induced Mitf expression to stimulate transdifferentiation in mouse cells. We generated MEFs from the engineered mouse chimera embryos and induced Mitf expression by supplementing growth media with Dox. Dox-treated Mitf knock-in MEFs acquired a dendrite like morphology that is a distinctive characteristic of melanocytes 24 ( Fig. 2a) whereas Mitf knock-in mESCs appearance remained unchanged ( Supplementary Fig. 1a ).
We then examined expression of known MITF target genes upon Dox induction. Mitf knock-in MEFs showed higher expression of melanogenic markers at 6 days post Dox induction than at earlier time points ( Supplementary Fig. 1b , c). We therefore treated
Mitf knock-in MEF and mESCs cells for 6 days and demonstrated upregulation of MITF target genes, TYRP1 and TYR ( Fig. 2b and Supplementary Fig. 1d ). Moreover, TYRP1 upregulation in Dox-treated MEFs compared to the vehicle-treated MEFs was demonstrated by immunostaining ( Fig. 2c ) and quantified ( Supplementary Fig. 1e , f).
MITF, as an expected of a transcription factor, was localized to the nucleus, whereas TYRP1 was found in the cytoplasm since it is part of the secreted pigment-producing vesicles 25 that are trafficked from melanocytes to adjacent cells 26 . Finally, to examine the global effect on the transcriptome, we performed a global mRNA expression profiling via RNA-seq. Genes differentially expressed in Mitf knock-in MEFs compared to vehicle-treated knock-in MEFs ( Supplementary Tables 1 and 2) were clustered and compared to expression in untreated wild-type MEFs and primary mouse melanocytes (PMel) (Fig. 2d ). This clustering demonstrates a gradual transition in the expression profile of Dox-treated Mitf knock-in MEFs toward the melanocyte expression profile ( Fig. 2d ). Likewise, Spearman correlation coefficients clearly demonstrate that Dox-treated Mitf knock-in MEFs (Dox+) are more similar to primary melanocytes (0.26) than to untreated Mitf knock-in MEFs (0.048), but overall Doxtreated knock-in MEFs are still more similar to wild-type MEFs (0.73) than to primary melanocytes ( Fig. 2e ). Indicating that Dox+ are MEFs that started to change upon primary melanocytes, but on the imaginary differentiation trajectory it are still closer to untreated MEFs. In summary, the Mitf inducible transgenic system recapitulated the previously reported transdifferentiation ability of MITF in mouse fibroblasts 27 . The higher efficiency is likely attributed to an optimized transgenic delivery of the reprogramming factor and to higher levels of factor induction than obtained during heterogeneous primary transduction with viruses 28 .
OCT4 impedes differentiation in mESCs despite MITF expression
Successful transdifferentiation by MITF in somatic cells encouraged us to further investigate our hypothesis in ESCs. Since naïve ESCs are pluripotent and their euchromatin to heterochromatin ratio is higher than in somatic cells 29 , we reasoned that ESCs might be favorable for manipulations, thereby enabling directed differentiation by MITF induction. In order to test this assumption, in addition to Mitf knock-in mESCs and Mitf knock-in MEFs, we also generated primary cell cultures from the intestine, heart, and brain of Mitf knock-in mouse chimeric newborns as these tissues represent the three germ layers endoderm, mesoderm, and ectoderm, respectively ( Fig. 3a) . We validated the quality of cell isolation by measuring expression of lineage specific markers ( Fig. 3b ). This analysis indicated high purity of isolation for each tissue. Next,
Mitf expression was induced in all of the indicated preparations by addition of Dox to the growth media for 6 days. Interestingly, Mitf was upregulated in all cell types, however, MITF target genes were not upregulated in mESCs, although these genes were upregulated in other tested somatic cell types ( Fig. 3c ).
In order to elucidate why mESCs were less responsive to Mitf induction, we profiled gene expression using the "BioGPS" gene annotation portal ( Supplementary Table 3 ).
Our first speculation was that mESCs, unlike the other cells, lack the expression of melanocyte lineage developmental genes such as Ednrb, Edn3, Sox10, and Pax3 13 ;
however, all of the investigated cells exhibited comparable expression amounts of melanocyte lineage developmental genes ( Fig. 3d ). This suggested that there are factors that prevent mESCs differentiation upon Mitf induction.
Possible candidates are OCT4, SOX2, and NANOGg, which are the core factors that maintain the pluripotent state and which play vital roles in the control of specific cell fates dependent on their defined levels 30,31 ,32 . In order to investigate whether one or more of these factors block MITF from upregulating its target genes, we first overexpressed OCT4, SOX2, or NANOG in MEFs followed by Mitf induction.
Interestingly, although Mitf was significantly induced, there was only minor upregulation of its specific target genes Tyrp1, Trpm1, and Tyrosinase when OCT4 was overexpressed ( Fig. 3e ). SOX2 overexpression blocked Trpm1 upregulation but not induction of Tyrp1 and Tyrosinase, suggesting a more dominant role for OCT4. OCT4
overexpression (confirmed as shown in Supplementary Fig. 2 ) in Dox-treated Mitf knock in MEFs also inhibited TYR activity ( Fig. 3f ) as shown using a florescent dye bound to the tyrosine analog tyramide, which is a substrate for TYR 33 . In a reciprocal experiment, we inhibited expression of Oct4, using validated shRNA compared to shcontrol, followed by Mitf induction in Mitf-inducible mESCs. Samples showed that Mitf upregulates its target genes Tyrp2, Trpm1, and Tyrosinase in mESCs deficient in Oct4 (Fig. 3g ).
In summary, the above data indicate that OCT4 impedes MITF activity in mESCs and in somatic cells upon ectopic expression of OCT4. This suggests that OCT4 protects against destabilization pluripotency potential, by blocking MITF pro-differentiation activity. We therefore reasoned that for a highly efficient directed differentiation of mESCs by Mitf induction, similarly to Mitf induced transdifferentiation of MEFs, a concomitant Oct4 suppression is required in order to release the stem cells from pluripotency.
OCT4 interferes with MITF transcriptional activity
To explore the mechanism underlying OCT4 interference with the pro-differentiation activity of MITF, we examined OCT4 and MITF genomic occupancy by analysis of ChIP-seq data of MITF in human melanocytes 34 and OCT4 in human ESCs 35 . We found that 26% of promoters bound by MITF were also bound by OCT4, and in 13% of these regions OCT4 bound within 10 Kb of the MITF-bound region ( Fig. 4a ). Of regions bound by MITF, 39% were also bound by OCT4 in a close proximity of less than 3Kb ( Fig. 4b ). For instance, regions upstream of TRPM1 and TYR, genes strongly related to melanocyte identity, were occupied by both MITF and OCT4 ( Fig. 4c ).
Moreover, TRPM1 and TYR promoter regions contained not only the well-documented MITF binding consensus site (the E-box) 12 but also the known OCT4 binding motif 36 ( Fig. 4c ).
Next, we tested the capability of OCT4 to influence MITF transcriptional activity by using reporter constructs in which luciferase expression was driven by the TRPM1 or TYR promoter. We compared effects of wild-type OCT4 to that of a mutated OCT4
which was phosphorylated in a site located within the OCT4 homeobox domain (T234 and S235) and found to negatively regulate OCT4 by disrupting sequence-specific DNA binding 37 . TRPM1 or TYR reporter was co-transfected with an MITF expression vector and wild-type or mutant OCT4 expression plasmid. Cells with high MITF levels, were co-transfected with TRPM1 or TYR reporters and wild-type or mutant OCT4 expression vector. In both systems, wild-type OCT4 significantly decreased MITF transcriptional activation of TRPM1 and TYR whereas mutant OCT4 did not ( Fig. 4d ).
OCT4 also inhibited MITF-induced transcription of mouse MLANA reporter ( Supplementary Fig. 3a ). SOX2 and NANOG overexpression in these systems did not inhibit expression from the reporters as OCT4 did ( Supplementary Fig. 3b ). When melanoma cells with high MITF levels were transfected with a vector for expression of OCT4 there was a reduction of both TRPM1 and TYR expression ( Fig. 4e ). Furthermore, melanoma cells with low MITF levels that were transfected with vectors for expression of MITF and OCT4 showed a significant decrease in TRPM1 mRNA levels compared to the control (Fig. 4e ). Interestingly, OCT4 and MITF are inversely correlated in different melanoma cell lines ( Supplementary Fig. 4a ) and seem to be uniquely expressed in skin cutaneous melanoma ( Supplementary Fig. 4b ).
To further study the OCT4 mechanism of action in regulating MITF transcriptional activity, co -immunoprecipitation experiments were performed to test their physical interaction. Cells were transfected with vectors for expression of MITF-HA and OCT4-Flag, and HA antibody was used for immunoprecipitation. In addition, cells that endogenously express MITF were transfected with OCT4-Flag, and immunoprecipitation was done using antibody against MITF. These experiments demonstrated that OCT4 and MITF physically interact ( Fig. 4f ; Supplementary Fig.   3c ). To confirm that there is a functional interaction between OCT4 and MITF, electrophoretic mobility shift assay (EMSA) experiments were conducted that demonstrated that MITF binding to the E-box consensus site in the TRPM1 promoter was blocked by OCT4 ( Fig. 4g ; Supplementary Fig. 3d ). Taken together, our data indicate that OCT4 interrupts MITF-mediated transcriptional activity by preventing MITF binding to the promoter region of its putative target genes.
Oct4 maintains pluripotency and prevents differentiation
Next, we aimed to explore whether OCT4 interference with MITF transcriptional activity is a global phenomenon and whether other somatic lineage commitment transcription factors are subjected to such regulation. Therefore, we analyzed ChIP-seq data of OCT4 and the following lineage transcription factors: MITF 34 , CDX2, GATA4 38 , and HES1 39 , which are central in the differentiation of melanocytes, intestinal cells, cardiac cells, and astrocytes, respectively ( Fig. 5a ). There was significant overlap of genes bound by OCT4 and these transcription factors (-log10 P-values for the overlap between OCT4 and MITF, 222.53; HES1, 177.38; GATA4, 235.73; CDX2, 193.11).
Using the DAVID functional annotation tool, we performed a Gene Ontology (GO) enrichment analysis of the co-bound genes (Supplementary Table 4 ). Significance of the obtained biological pathways was determined according to Benjamini-Hochberg multiple testing rate. The pathways that were considered significant scored below 0.05 in this parameter. The identified biological pathways clearly showed that OCT4
occupies promoters of genes that are essential for specific lineage development ( Fig.   5b ). For example, GO analysis of genes co-bound by OCT4 and MITF revealed significant enrichment of the melanin pigmentation process, which uniquely characterizes melanocytes and is also known to be regulated by MITF 40 . Similarly, analysis of OCT4 and GATA4 bound genes revealed significant enrichment in genes involved in cardiac development, which is known to be regulated by GATA4 41, 42 .
Importantly, the non-overlapping genes yielded only general biological pathways and not genes known to be regulated by the lineage-specific transcription factors (Supplementary Table 5 ).
In order to explore whether OCT4 uniquely occupies promoters of genes involved in developmental lineage pathways, we analyzed ChIP-seq data of the general transcription factor E2F7 for overlap with MITF-bound genes. In the GO analysis of co-bound genes we found no significant enrichment in developmental pathways (Supplementary Table 6 ; Supplementary Fig. 5a , b). Additional analyses of MITF ChIP-seq data generated in normal melanocytes 43 with ChIP-seq peaks of OCT4, E2F7, or P53, followed by GO analysis of overlapping genes (Supplementary Table 6 ) showed that only MITF and OCT4 co-bound genes resulted in significant melanocyte differentiation pathway enrichment ( Supplementary Fig. 5 ). No enrichment in genes involved in differentiation was observed in the genes bound by MITF and E2F7 or P53.
No other classes of genes were significantly enriched in these overlapping targets.
These data suggest that OCT4 occupies lineage-specific gene promoters in order to prevent transcriptional activity under inappropriate timing. To test this hypothesis in vivo, we used mice in which Oct4 expression was inducible 44 . We derived transgenic melanocytes and cell cultures from the brain, heart, and intestine of newborns (Fig. 5c ).
The expression of cell type specific markers was significantly decreased following Oct4 induction ( Fig. 5d ).
We also examined OCT4 in relation to other transcription factors in another regulatory layer of chromosome organization. The Hi-C method was developed to enable exploration of genome-wide chromosomal associations 45 . Segments of internal high spatial connectivity termed "topologically associating domains" (TADs) 46, 47 . Clustering of genes that in TADs are co-regulated in nuclear sub-compartments, which comprise the contact domains, may facilitate their co-regulation by favoring frequent engagement with enhancers within TADs while insulating the influence of the enhancers beyond the TAD borders create nuclear microenvironments that are enriched in specific factors that coordinate the expression or repression of specific groups of genes 48, 49 . Since TAD borders are stable acress different cell types 50 , we integrated Hi-C data of human lymphoblastoid cells together with ChIP-seq data. This analysis showed a significant sharing domain binding between OCT4 and a number of transcription factors in TADs ( Fig. 5e ). Assuming that the loci bound by transcription factors are connected in three dimensions to genes within the same TAD, the enrichment of particular transcription factors in the same TAD suggests that they co-regulate genes found in the TAD. To visually demonstrate our analysis, we used "Juicebox" software for visualizing data from Hi-C mapping experiments. By this analysis, for example, the MITF target gene TRPM1 was found to be in an OCT4 and MITF shared TAD ( Fig. 5f ), supporting our hypothesis that OCT4 interferes with MITF transcriptional activity by sharing the same TADs ( Supplementary Table 7 ). These findings indicate that cell type-specific regulatory sites can be engaged by a combination of transcription factors in a cooperative manner.
Finally, we analyzed the enhancers occupied by MITF and determined whether OCT4 or P53 co-bind these regions ( Supplementary Table 8 ). We counted the number of MITF, OCT4, and P53 ChIP-seq peaks within ESCs enhancers. We found that 1.6% of enhancers are bound by MITF and 11% of MITF-bound enhancers are also bound by OCT4 (-log(p-value=122)). In contrast, only 0.57% of MITF-bound enhancers are also bound by P53 (-log(p-value=5)) ( Fig. 5g ). This result implies that the regulatory interaction between MITF and OCT4 occurs in both enhancers and promotors. This strengthens our hypothesis that there is a transcriptional regulatory competition between MITF and OCT4.
Discussion
Transdifferentiation of somatic cells can be achieved by the expression of a specific set of transcription factors. It has been reported that the expression of MITF alone or in combination with other transcription factors can induce transdifferentiation of fibroblasts into cells with melanocyte characteristics 18, 19 . In this study, we first showed that MEFs can be induced to transition into melanocyte-like cells with high efficiency using an optimized Dox-dependent Mitf knock-in system. We also demonstrated that MITF was able to transdifferentiate the investigated somatic cells. Our findings confirm the role of MITF as a master regulator of melanocytes, reminiscent of the master role of MyoD in inducing fibroblast transdifferentiation into muscle 51 .
To date, most protocols designed to induce changes in cell fate have focused on reprogramming of a specific cell type 4,5 and these protocols have not been systemically characterized 51 . Here we evaluated a repertoire of primary somatic and embryonic stem cells that originated from the same mouse model and subjected them to the induction of a master differentiation and transdifferentiation regulator, MITF. In contrast to previous reports of transdifferentiation in which indicated that effects of expression of a master regulator were limited to target cells closely related to the originating cells 4 , we observed highly efficient induction of transdifferentiation that was not restricted to a specific cell type. We demonstrated transdifferentiation of cells from all three germ layers, however, mESCs did not exhibit a transition into melanocyte-like cells upon Mitf induction.
Since ESCs possess a more open chromatin configuration than somatic cells and thus have higher developmental plasticity, we expected that ESCs would be more susceptible to transcription factor occupancy than somatic cells. Interestingly, although
Mitf was induced at high levels in ESCs, it did not promote efficient differentiation into melanocytes. In order to identify the factor responsible for blocking MITF-induced differentiation of ESCs, we focused on the pluripotent master regulators OCT4, SOX2, and NANOG since all are well established to control pluripotent cell fate decisions 30, 31, 32 . This suggests that OCT4 may inhibit the induction of differentiation by MITF in pluripotent cells by physical interaction with MITF, thus interfering MITF from regulating its target genes.
The role of OCT4 in reprogramming of somatic cells into pluripotent stem cells has been widely studied 52 Interestingly, when comparing OCT4 35 , SOX2, and NANOG promoter occupancies 54 , OCT4 and NANOG together seem to engage more gene promoters than combinations of OCT4 and SOX2 or SOX2 and NANOG ( Supplementary Fig. 6 ). OCT4 also occupies gene promoter regions and topological domains of somatic lineage transcription factor target genes as well.
Taken together our observations strongly suggest that the ability of MITF to differentiate pluripotent mESCs is tempered by OCT4 interference ( Supplementary Fig.   7 ) at the transcriptional level. That expression of MITF, which serves as a model for other lineage master regulators, efficiently switched cell fate of inter germ layers opens new opportunities in the field of regenerative medicine. It will be of interest to validate a role for OCT4 in human somatic cell reprogramming as well. 
Methods
Mice
Southern blot
Genomic DNA was extracted from each hygromycin-resistant targeted subclone. 10-15 μg of genomic DNA was digested with SpeI restriction enzyme for 5 h and separated by gel electrophoresis. The DNA was transferred to a nitrocellulose membrane that was next hybridized with a radioactively labeled probe and developed using enhanced chemiluminescent substrate (Thermo Scientific).
Engineered primary somatic cell generation
Newborn were used at day 1-3. Melanocytes were extracted from the epidermis. Skin was removed into 0.25% trypsin and incubated overnight at 4ºC. Next, dermis and epidermis were separated. Epidermis was incubated at 37°C in 0.25% trypsin for 30 minutes and then dispersed into small pieces and covered with melanocyte media. The cells were not touched until day 4 post extraction. Cells from the brain were obtained based on Saura et al 56 . Cells from heart and intestine were isolated based on Song et al 57 . Shortly, heart and intestine were dispersed by addition of 0.625 mg/ml collagenase (type II; Worthington) and incubated at 37ºC for 40 min. Cells were resuspended with fresh DMEM with 10% FCS and centrifuged at 1000 rpm for 3 min. Cell pellet was suspended in DMEM with 10% FCS. Cells originated from the heart were plated on gelatin coated plates.
Transfection and luciferase reporter assay
Luciferase reporter driven constructs were co-transfected with the pcDNA3-MITF-HA or empty plasmid into HEK293T cells or WM3682 in 24-well plates (total of 1 μg DNA/well) using jetPEI™ for HEK293T or TransIT-X2® for WM3682 according to the manufacturer's instructions. Cell lysates were prepared 48h after transfection, followed by activity measurement of FireFly luciferase, using the Dual Luciferase kit 
Immunostaining
MEFs were cultured on glass cover slips (13 mm, 1.5 H; Marienfeld, 0117530), washed three times with PBS and fixated with 4% paraformaldehyde for 10 min at room temperature. Cells were then permeabilized and blocked in 0.1% Triton, 0.1% Tween and 5% FBS in PBS for 15 min at room temperature. Primary antibodies were incubated for 2 h at room temperature and then washed with 0.1% Tween and 1% FBS in PBS three times. Next, cells were incubated with secondary antibody for 1 h at room temperature, washed and counterstained with DAPI, mounted with Shandon Immu-Mount (Thermo Scientific) and imaged. All secondary antibodies were diluted 1:200.
The following antibodies were used: rabbit anti MITF antibody (a gift from the David E Fisher lab, DF/HCC). rabbit anti-TYRP1 (a gift from the Vincent Hearing lab, NCI).
Mouse monoclonal ANTI-FLAG®M2 antibody (Sigma-Aldrich).
Co-Immunopercipitation (Co-IP)
pcDNA3-MITF-HA and pcDNA3-OCT4-Flag were transfected individually or together into HEK293T cells in 10cm culture plate (total of 10 μg DNA/well). WM3682 cells were transfected with pcDNA3-OCT4-Flag. Cell lysates were prepared 48h after transfection using IP buffer containing protease inhibitor cocktail (Sigma-Aldrich). 
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared using a NE-PER nuclear and cytoplasmic extraction kit Labeled DNA was visualized with the ECL system (Pierce). The super-shift assay is shown in Supplementary Figure 6 . Probe sequence for the MITF binding site is listed
in Supplementary Table 12 . The wild-type probe was derived from the TRPM1 promoter, which was shown to bind MITF 58 .
Tyramide-Based Tyrosinase Activity Assay
The assay was performed according to 59 
Microscopy and image analysis
Images were acquired with A1 Axioscope microscope (Carl Zeiss) equipped with DP73 camera (Olympus) or with Z1 Axioscope microscope (Carl Zeiss), Fluorescent images were quantitatively analyzed using ImageJ software.
Enrichment of OCT4 and lineage TFs in Hi-C domains:
Genomic Spearman correlation as a distance metric, ward linkage, and per-row standardization (zscore) (Fig 2.d) .
Promoter and Enhancer analysis
ChIP-seq peaks of each transcription factor were collected from the ENCODE project consortium 61 and assigned to promoters (using different transcription start site (TSS) distances to define promoters) and enhancers (using human embryonic stem cells enhancers as defined by Ernst et al 62 
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